Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Lipase CALB. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN119899823A reveals a novel lipase mutant enabling mild, cost-effective production of chiral pharmaceutical intermediates with superior stereoselectivity.
Advanced lipase CALB mutant technology enables high-purity pharmaceutical intermediates manufacturing with reduced costs and enhanced supply chain reliability for global buyers.